Leeds AI spinout adsilico raises £10M to test medical devices on virtual patients
adsilico, founded in 2024 by Sheena Macpherson, Dr Nishant Ravikumar and Dr Zeike Taylor, uses generative AI to create virtual hearts and blood vessels from anonymized clinical scans. The platform combines these models with physics-based simulations to assess medical device performance across diverse patient demographics before clinical trials. The Series A round, led by PXN Ventures with participation from Northern Gritstone and Parkwalk, enables the startup to expand its Virtual Chimera platform, which helps device makers evaluate performance variations by age, sex, ethnicity, body size and medical conditions.
Key points
- Series A round led by PXN Ventures with Northern Gritstone and Parkwalk participation
- Virtual Chimera platform creates AI-generated virtual anatomies for device testing
- Helps medical device makers identify risks and refine clinical trial strategies before human trials
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Tech.eu did the reporting; read the original for the full story.
Read the full story at Tech.eu
